IDH1 and central nervous system cancer: Immunostaining analysis revealed high levels of praja2 in primary GBM tissues carrying wild-type IDH1, compared to mutant IDH1 low-grade glioma (astrocytoma) and secondary GBM (Fig. 1a, b).